Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 12/20 | 0.67 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | FDPS | P14324 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29446967 | 1.00 | NISCH (0.67) | NISCHMAOBACHEFDPSALDH1A1 | |
| Hydrochloric Acid SCHEMBL27888413 | 0.98 | NISCH (0.65) | NISCHMAOBACHEFDPS | |
| Hydrochloric Acid SCHEMBL29755905 | 0.98 | NISCH (0.65) | NISCHMAOBACHEFDPS | |
| Hydrochloric Acid SCHEMBL1143198 | 0.97 | NISCH (0.63) | NISCHMAOBACHEFDPS | |
| SCHEMBL8195024 | 0.92 | NISCH (0.67) | NISCHMAOBFDPSALDH1A1CYP1A2 | |
| SCHEMBL7015982 | 0.90 | NISCH (0.64) | NISCHMAOBACHE | |
| SCHEMBL9189709 | 0.87 | NISCH (0.85) | NISCHMAOBACHE | |
| SCHEMBL8201474 | 0.85 | NISCH (0.69) | NISCHMAOB | |
| SCHEMBL16275243 | 0.81 | NISCH (0.60) | NISCHMAOB | |
| SCHEMBL24495491 | 0.80 | NISCH (1.00) | NISCHMAOBACHEALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813551-A | Preparation method of imidazole phenylurea dipropionate | 齐鲁晟华制药有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-114773270-A | Production and preparation method of imidocarb dipropionate | 山东省药学科学院 | 2022-07-22 | — | — | CN | claimed |
| CN-111574455-A | Preparation method of imidocarb dipropionate and intermediate thereof | 山东省药学科学院 | 2020-08-25 | — | — | CN | claimed |
| CN-110256354-A | A kind of imidocard dipropionate impurity A and its impurity A preparation method | 齐鲁动物保健品有限公司 | 2019-09-20 | — | — | CN | claimed |
| CN-106957265-A | The preparation method of 2 (3 aminophenyl) imidazoline hydrochlorides and imidazophenylurea | 灌南伊斯特化工有限公司 | 2017-07-18 | — | — | CN | claimed |
| CN-102924380-A | Preparation method of imidocarb | QILU ANIMAL HEALTH PRODUCTS CO | 2013-02-13 | — | — | CN | claimed |
| CN-102898375-A | Preparation method of 2-(3-aminophenyl) imidazoline hydrochloride | QILU ANIMAL HEALTH PRODUCTS CO | 2013-01-30 | — | — | CN | claimed |
| CN-114671810-B | Preparation method of imidazole phenylurea | 济南鸿湾生物技术有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-116813551-A | Preparation method of imidazole phenylurea dipropionate | 齐鲁晟华制药有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116621781-A | Preparation method of 2- (3-nitrophenyl) -4, 5-dihydro-1H-imidazoline | 济南鸿湾生物技术有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-114773270-A | Production and preparation method of imidocarb dipropionate | 山东省药学科学院 | 2022-07-22 | — | — | CN | disclosed |
| CN-114671810-A | Preparation method of imidocarb | 济南鸿湾生物技术有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-110950962-B | Hybridoma cell strain A11S for secreting bimesomepheniul monoclonal antibody and application thereof | 江南大学 | 2022-03-15 | — | — | CN | disclosed |
| WO-2009145829-A1 | TYPE III SECRETION INHIBITORS, ANALOGS AND USES THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2009-12-03 | — | — | WO | disclosed |
| US-20090194124-A1 | Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine | MALLE GERARD | 2009-08-06 | — | — | US | disclosed |
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | L'OREAL S.A. | 2009-06-04 | — | — | US | disclosed |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | L'OREAL S.A. (FR) | 2005-06-23 | — | — | US | disclosed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | disclosed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | KRT18, INMT, INHA | NISCH 153/4885MAOB 862/4885ACHE 740/4885 |
| US-20090194124-A1 | Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine | KRT18, KIT, PRDM7 | NISCH 48/4885MAOB 1998/4885ACHE 2175/4885 |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | KRT18, INHA, H1-5 | NISCH 50/4885MAOB 2375/4885ACHE 2666/4885 |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | BHMT, KRT18, INMT | NISCH 45/4885MAOB 553/4885ACHE 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.